BeStock  
Stocks › Gene Editing › BEAM

Beam Therapeutics BEAM

US equityMarket cap rank #2634AI medical concept stocksGene Editing
$20.90 −$0.04 (-0.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $21.66 +3.65%
Open$20.60
Prev close$20.94
Day range$20.54 – $22.10
Volume3.89M
Market cap$2.16B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts12
Average target$49.36+136.2% vs. price
  • Buy 92%
  • Hold 8%
Low $26.00Now $20.90Avg $49.36High $80.00

Recent rating changes

The last 20 actions on file set price targets from $26.00 to $80.00, averaging $61.75.

DateFirmRatingTarget
11 Nov 2026 CCORF BUY $78.00
11 Nov 2026 H.C. Wainwright BUY $80.00
10 Nov 2026 Wedbush BUY $33.00
10 Nov 2026 Citi BUY $68.00
10 Nov 2026 H.C. Wainwright BUY $80.00
6 Nov 2026 H.C. Wainwright BUY $80.00
5 Nov 2026 Guggenheim BUY $51.00
4 Nov 2026 CCORF BUY $78.00
4 Nov 2026 BofA Securities BUY $41.00
4 Nov 2026 Wedbush BUY $30.00
3 Nov 2026 Jefferies BUY $49.00
3 Nov 2026 RBC Capital HOLD $26.00
29 Oct 2026 CCORF BUY $79.00
28 Oct 2026 Evercore BUY $45.00
27 Oct 2026 BofA Securities BUY $43.00
27 Oct 2026 Citi BUY $68.00
27 Oct 2026 H.C. Wainwright BUY $80.00
15 Oct 2026 H.C. Wainwright BUY $80.00
14 Oct 2026 CCORF BUY $78.00
13 Oct 2026 Citi BUY $68.00

Discussion

No comments yet — be the first to weigh in on BEAM.

Sign in to join the discussion.

Scroll to Top